Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Asian herbal-tobacco cigarettes: "not medicine but less harmful"?

Chen A, Glantz S, Tong E.

Tob Control. 2007 Apr;16(2):e3. Review.

3.

No sisyphean task: how the FDA can regulate electronic cigarettes.

Paradise J.

Yale J Health Policy Law Ethics. 2013 Summer;13(2):326-74.

PMID:
24340824
4.

Chinese "herbal" cigarettes are as carcinogenic and addictive as regular cigarettes.

Gan Q, Yang J, Yang G, Goniewicz M, Benowitz NL, Glantz SA.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3497-501. doi: 10.1158/1055-9965.EPI-09-0620.

5.

Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.

Peeters S, Gilmore AB.

PLoS Med. 2013;10(9):e1001506. doi: 10.1371/journal.pmed.1001506. Epub 2013 Sep 10.

6.

Marketing 'less harmful, low-tar' cigarettes is a key strategy of the industry to counter tobacco control in China.

Yang G.

Tob Control. 2014 Mar;23(2):167-72. doi: 10.1136/tobaccocontrol-2012-050691. Epub 2013 Jan 24.

7.

The strategic targeting of females by transnational tobacco companies in South Korea following trade liberalization.

Lee K, Carpenter C, Challa C, Lee S, Connolly GN, Koh HK.

Global Health. 2009 Jan 30;5:2. doi: 10.1186/1744-8603-5-2.

8.

Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.

Pauly JL, Mepani AB, Lesses JD, Cummings KM, Streck RJ.

Tob Control. 2002 Mar;11 Suppl 1:I51-61. Review.

9.

Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.

Milberger S, Davis RM, Douglas CE, Beasley JK, Burns D, Houston T, Shopland D.

Tob Control. 2006 Dec;15 Suppl 4:iv17-26.

10.

Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation.

Velicer C, Lempert LK, Glantz S.

Tob Control. 2015 Sep;24(5):469-80. doi: 10.1136/tobaccocontrol-2014-051571. Epub 2014 Jun 11.

11.

Smoker and ex-smoker reactions to cigarettes claiming reduced risk.

Shiffman S, Pillitteri JL, Burton SL, Di Marino ME.

Tob Control. 2004 Mar;13(1):78-84.

12.

Smoker awareness of and beliefs about supposedly less-harmful tobacco products.

O'Connor RJ, Hyland A, Giovino GA, Fong GT, Cummings KM.

Am J Prev Med. 2005 Aug;29(2):85-90.

PMID:
16005803
15.

Transnational tobacco industry promotion of the cigarette gifting custom in China.

Chu A, Jiang N, Glantz SA.

Tob Control. 2011 Jul;20(4):e3. doi: 10.1136/tc.2010.038349. Epub 2011 Jan 30.

16.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
17.

Cigarettes sold in China: design, emissions and metals.

O'Connor RJ, Li Q, Stephens WE, Hammond D, Elton-Marshall T, Cummings KM, Giovino GA, Fong GT.

Tob Control. 2010 Oct;19 Suppl 2:i47-53. doi: 10.1136/tc.2009.030163.

18.

Menthol: putting the pieces together.

Lee YO, Glantz SA.

Tob Control. 2011 May;20 Suppl 2:ii1-7. doi: 10.1136/tc.2011.043604. Review.

19.

Tobacco as a social currency: cigarette gifting and sharing in China.

Rich ZC, Xiao S.

Nicotine Tob Res. 2012 Mar;14(3):258-63. doi: 10.1093/ntr/ntr156. Epub 2011 Aug 17. Review.

PMID:
21849412
20.

Supplemental Content

Support Center